Qiming Corporate GP VI, Ltd. bought ALMR
April 20, 2026 · Form 4 insider transaction
Qiming Corporate GP VI, Ltd. bought 6,881,410 shares of Alamar Biosciences, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date.; Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date.; These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.